Relay Therapeutics, Inc.
RLAY
$19.86
-$0.07-0.35%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -286.04M | -272.71M | -276.48M | -297.59M | -311.55M |
| Total Depreciation and Amortization | 2.21M | 2.85M | 3.56M | 4.29M | 4.91M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 45.33M | 52.80M | 60.77M | 63.88M | 68.41M |
| Change in Net Operating Assets | 26.29M | 3.70M | -23.31M | -19.04M | -23.19M |
| Cash from Operations | -212.21M | -213.36M | -235.46M | -248.46M | -261.42M |
| Capital Expenditure | 0.00 | -26.00K | -410.00K | -409.00K | -637.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -244.94M | 183.26M | 193.21M | 186.74M | 21.08M |
| Cash from Investing | -244.94M | 183.24M | 192.80M | 186.33M | 20.45M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 463.47M | 140.39M | 1.60M | 1.47M | 220.34M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 463.47M | 140.39M | 1.60M | 1.47M | 220.34M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.33M | 110.26M | -41.05M | -60.65M | -20.63M |